First, we evaluated the accuracy of DeepMEL2 and other methods to predict functional changes across the TERT promoter, by comparing the predictions to a previously published saturation mutagenesis screen performed in a glioblastoma cell line (Kircher et al. 2019). Here, TERT is linked to glioblastoma.